Viriom ' s Single Pill Influenza Treatment Completes Critical Phase I Clinical Trials

SAN DIEGO, Nov. 20, 2023. Viriom Inc., dedicated to advancing a pipeline of highly effective and broadly affordable treatments targeting infectious and malignant diseases globally, announces the successful completion and positive results of Phase I...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials